目次

Table of Contents

Executive Summary
Market overview

Market Landscape
Market ecosystem
Value chain analysis

Market Sizing
Market definition
Market segment analysis
Market size 2020
Market outlook: Forecast for 2020 - 2025

Five Forces Analysis
Five forces summary
Bargaining power of buyers
Bargaining power of suppliers
Threat of new entrants
Threat of substitutes
Threat of rivalry
Market condition

Market Segmentation by Application
Market segments
Comparison by Application
Therapeutics - Market size and forecast 2020-2025
Diagnostics - Market size and forecast 2020-2025
Market opportunity by Application

Customer landscape
Customer landscape

Geographic Landscape
Geographic segmentation
Geographic comparison
North America - Market size and forecast 2020-2025
Europe - Market size and forecast 2020-2025
Asia - Market size and forecast 2020-2025
ROW - Market size and forecast 2020-2025
Key leading countries
Market opportunity by geography
Market drivers
Market challenges
Market trends

Vendor Landscape
Overview
Landscape disruption

Vendor Analysis
Vendors covered
Market positioning of vendors
4D pharma Plc
ENTEROME SA
Evelo Biosciences Inc.
Ferring Pharmaceuticals AS
Osel Inc.
Second Genome Therapeutics
Seres Therapeutics Inc.
Synlogic Inc.
Synthetic Biologics Inc.
Vedanta Biosciences Inc.

Appendix
Scope of the report
Currency conversion rates for US$
Research methodology
List of abbreviations

Exhibits
1: Key Finding 1
2: Key Finding 2
3: Key Finding 3
4: Key Finding 5
5: Key Finding 6
6: Key Finding 7
7: Key Finding 8
8: Parent market
9: Market characteristics
10: Offerings of vendors included in the market definition
11: Market segments
12: Global - Market size and forecast 2020 - 2025 ($ million)
13: Global market: Year-over-year growth 2020 - 2025 (%)
14: Five forces analysis 2020 & 2025
15: Bargaining power of buyers
16: Bargaining power of suppliers
17: Threat of new entrants
18: Threat of substitutes
19: Threat of rivalry
20: Market condition - Five forces 2020
21: Application - Market share 2020-2025 (%)
22: Comparison by Application
23: Therapeutics - Market size and forecast 2020-2025 ($ million)
24: Therapeutics - Year-over-year growth 2020-2025 (%)
25: Diagnostics - Market size and forecast 2020-2025 ($ million)
26: Diagnostics - Year-over-year growth 2020-2025 (%)
27: Market opportunity by Application
28: Customer landscape
29: Market share by geography 2020-2025 (%)
30: Geographic comparison
31: North America - Market size and forecast 2020-2025 ($ million)
32: North America - Year-over-year growth 2020-2025 (%)
33: Europe - Market size and forecast 2020-2025 ($ million)
34: Europe - Year-over-year growth 2020-2025 (%)
35: Asia - Market size and forecast 2020-2025 ($ million)
36: Asia - Year-over-year growth 2020-2025 (%)
37: ROW - Market size and forecast 2020-2025 ($ million)
38: ROW - Year-over-year growth 2020-2025 (%)
39: Key leading countries
40: Market opportunity by geography ($ million)
41: Impact of drivers and challenges
42: Vendor landscape
43: Landscape disruption
44: Industry risks
45: Vendors covered
46: Market positioning of vendors
47: 4D pharma Plc - Overview
48: 4D pharma Plc - Product and service
49: 4D pharma Plc - Key offerings
50: 4D pharma Plc - Key customers
51: 4D pharma Plc - Segment focus
52: ENTEROME SA - Overview
53: ENTEROME SA - Product and service
54: ENTEROME SA - Key offerings
55: ENTEROME SA - Key customers
56: ENTEROME SA - Segment focus
57: Evelo Biosciences Inc. - Overview
58: Evelo Biosciences Inc. - Product and service
59: Evelo Biosciences Inc. - Key offerings
60: Evelo Biosciences Inc. - Key customers
61: Evelo Biosciences Inc. - Segment focus
62: Ferring Pharmaceuticals AS - Overview
63: Ferring Pharmaceuticals AS - Product and service
64: Ferring Pharmaceuticals AS - Key offerings
65: Ferring Pharmaceuticals AS - Key customers
66: Ferring Pharmaceuticals AS - Segment focus
67: Osel Inc. - Overview
68: Osel Inc. - Product and service
69: Osel Inc. - Key offerings
70: Osel Inc. - Key customers
71: Osel Inc. - Segment focus
72: Second Genome Therapeutics - Overview
73: Second Genome Therapeutics - Product and service
74: Second Genome Therapeutics - Key offerings
75: Second Genome Therapeutics - Key customers
76: Second Genome Therapeutics - Segment focus
77: Seres Therapeutics Inc. - Overview
78: Seres Therapeutics Inc. - Product and service
79: Seres Therapeutics Inc. - Key offerings
80: Seres Therapeutics Inc. - Key customers
81: Seres Therapeutics Inc. - Segment focus
82: Synlogic Inc. - Overview
83: Synlogic Inc. - Product and service
84: Synlogic Inc. - Key offerings
85: Synlogic Inc. - Key customers
86: Synlogic Inc. - Segment focus
87: Synthetic Biologics Inc. - Overview
88: Synthetic Biologics Inc. - Product and service
89: Synthetic Biologics Inc. - Key offerings
90: Synthetic Biologics Inc. - Key customers
91: Synthetic Biologics Inc. - Segment focus
92: Vedanta Biosciences Inc. - Overview
93: Vedanta Biosciences Inc. - Product and service
94: Vedanta Biosciences Inc. - Key offerings
95: Vedanta Biosciences Inc. - Key customers
96: Vedanta Biosciences Inc. - Segment focus
97: Currency conversion rates for US$
98: Research Methodology
99: Validation techniques employed for market sizing
100: Information sources
101: List of abbreviations